Literature DB >> 12645086

Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice.

Yue-guo Chen1, Cheng Zhang, Samuel K S Chiang, Tinghuai Wu, Mark O M Tso.   

Abstract

Nuclear factor-kappaB (NF-kappaB) is a universal transcription factor and has previously been demonstrated to play an important role in CNS injury. This study investigated the expression of NF-kappaB in the inner layers of the retina in mice after retinal ischemia and reperfusion injury. Retinal ischemia was induced by elevation of intraocular pressure to 120 mmHg for 60 min. To evaluate inner retinal degeneration, the inner retinal thickness was quantified with an image-analysis system. The inner retinal thickness increased in the initial 24 hr after retinal ischemia and was ascribed to tissue edema but was significantly decreased in the ensuing 7 days. Immunohistochemistry using NF-kappaB p65 monoclonal antibody was performed on the retina and was corelated with TUNEL labeling. Six hours after retinal ischemia, nuclear p65 immunoreactivity was increased in the inner nuclear and ganglion cell layers and reached a peak at 24 hr. The increased NF-kappaB p65 immunolabeling was parallel to the TUNEL labeling. Double labeling with p65 and TUNEL showed partial colocalization of p65 and TUNEL labeling in the scattered cells of the inner nuclear and ganglion cell layers. However, several p65-positive cells were TUNEL negative, suggesting that these cells might have survived the injury. The NF-kappaB p65 immunoreactivity was associated with retinal degeneration following retinal ischemia and reperfusion injury. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645086     DOI: 10.1002/jnr.10548

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Neuroglobin protection in retinal ischemia.

Authors:  Anita S Y Chan; Sindhu Saraswathy; Matus Rehak; Mari Ueki; Narsing A Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

Review 2.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

3.  Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion.

Authors:  Harumasa Yokota; Subhadra P Narayanan; Wenbo Zhang; Hua Liu; Modesto Rojas; Zhimin Xu; Tahira Lemtalsi; Taiji Nagaoka; Akitoshi Yoshida; Steven E Brooks; Robert W Caldwell; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

4.  The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.

Authors:  Galina Dvoriantchikova; Eleut Hernandez; Jeff Grant; Andrea Rachelle C Santos; Huan Yang; Dmitry Ivanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

5.  Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.

Authors:  Mohammed M H Al-Gayyar; Mohammed A Abdelsaid; Suraporn Matragoon; Bindu A Pillai; Azza B El-Remessy
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  Short-term high-fat feeding exacerbates degeneration in retinitis pigmentosa by promoting retinal oxidative stress and inflammation.

Authors:  Oksana Kutsyr; Agustina Noailles; Natalia Martínez-Gil; Lucía Maestre-Carballa; Manuel Martinez-Garcia; Victoria Maneu; Nicolás Cuenca; Pedro Lax
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

7.  Pharmacologic intervention targeting glycolytic-related pathways protects against retinal injury due to ischemia and reperfusion.

Authors:  Ling Zheng; Shuqing Liu; Ming-Zhong Sun; Jinsook Chang; Mark R Chance; Timothy S Kern
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

8.  Glutamate-induced NFkappaB activation in the retina.

Authors:  Wei Fan; Nigel G F Cooper
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

9.  p38 mitogen-activated protein kinase-induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for neuroprotection in retinal ischemia/reperfusion injury.

Authors:  Shao-Yun Jiang; Yuan-Yuan Zou; Jian-Tao Wang
Journal:  Mol Vis       Date:  2012-07-26       Impact factor: 2.367

10.  The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.

Authors:  Fang-Ting Chen; Chung-May Yang; Chang-Hao Yang
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.